Human antibody specific for interleukin-1 alpha
US10899833B2 · kind B2 · utility
3Cited by
7References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 20, 2017 |
| Grant date | Jan 26, 2021 |
| Priority date | — |
| Expiry date | Nov 24, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fully human monoclonal Abs includes (i) an antigen-binding variable region that exhibits very high binding affinity for IL-1α and (ii) a constant region that is effective at both activating the complement system though C1q binding and binding to several different Fc receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.